Utilization of exenatide once-weekly (Bydureon (R)) in primary Care in England: Results from a PASS

Dhanda, S; Osborne, V; Roy, D; Shakir, S

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019; 28 (): 515